Hansa Biopharma Strengthens Leadership: 25-Year Drug Development Veteran with 4 FDA Approvals Named CMO
Summary by stocktitan.net
2 Articles
2 Articles
All
Left
Center
Right
Richard Philipson appointed as chief medical officer of Hansa Biopharma - Pharmafile
Hansa Biopharma has announced that Richard Philipson has been appointed chief medical officer, effective 14 July. Philipson will join the executive committee and will report to recently appointed CEO, Renée Aguiar-Lucander. Philipson brings over 25 years of experience across numerous phases of clinical development, including regulatory strategy, budgetary management and developing treatments for rare diseases. […] The post Richard Philipson appo…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium